Showing results (311-320 of 350) with videos related to

Sort By:
Pageof 35
Scientific Reports|October 22, 2021
Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patientsFumiaki Watanabe, Koichi Suzuki, Sawako Tamaki, et al.
Thyroid : Official Journal of the American Thyroid Association|December 14, 2012
Demonstration of innate immune responses in the thyroid gland: potential to sense danger and a possible trigger for autoimmune reactionsAkira Kawashima, Kazuko Yamazaki, Takeshi Hara, et al.
Analytical and Bioanalytical Chemistry|August 6, 2013
Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preferenceKei Zaitsu, Izuru Miyawaki, Kiyoko Bando, et al.
Plos One|January 1, 2020
Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancerFumiaki Watanabe, Koichi Suzuki, Sawako Tamaki, et al.
Plos One|March 26, 2021
Mycobacterium leprae promotes triacylglycerol de novo synthesis through induction of GPAT3 expression in human premonocytic THP-1 cellsKazunari Tanigawa, Yasuhiro Hayashi, Kotaro Hama, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Expression of PDS/Pds, the Pendred syndrome gene, in endometriumKoichi Suzuki, Ines E Royaux, Lorraine A Everett, et al.
Plos Neglected Tropical Diseases|January 31, 2018
Mycobacterium leprae genomes from naturally infected nonhuman primatesTanvi P Honap, Luz-Andrea Pfister, Genevieve Housman, et al.
Life Sciences|July 31, 2018
Metabolome analysis of the serotonin syndrome rat model: Abnormal muscular contraction is related to metabolic alterations and hyper-thermogenesisKei Zaitsu, Saki Noda, Akira Iguchi, et al.
Molecular and Clinical Oncology|April 25, 2022
Prophylactic use of pegfilgrastim enables the management of severe neutropenia without dose delays in patients with metastatic colorectal cancer treated with TAS-102 plus bevacizumabSawako Tamaki, Hideki Ishikawa, Koichi Suzuki, et al.
Oncology Reports|March 6, 2017
Clinical and molecular assessment of regorafenib monotherapyNao Kakizawa, Koichi Suzuki, Taro Fukui, et al.
Pageof 35